A detailed history of Kimelman & Baird, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kimelman & Baird, LLC holds 16,300 shares of AMGN stock, worth $4.3 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
16,300
Previous 16,400 0.61%
Holding current value
$4.3 Million
Previous $5.12 Billion 2.49%
% of portfolio
0.42%
Previous 0.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$309.38 - $337.38 $30,938 - $33,738
-100 Reduced 0.61%
16,300 $5.25 Billion
Q2 2024

Aug 19, 2024

BUY
$262.75 - $319.31 $3.36 Million - $4.09 Million
12,800 Added 355.56%
16,400 $5.12 Billion
Q2 2019

Nov 22, 2019

BUY
$166.7 - $195.41 $600,120 - $703,476
3,600 New
3,600 $663,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Kimelman & Baird, LLC Portfolio

Follow Kimelman & Baird, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kimelman & Baird, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kimelman & Baird, LLC with notifications on news.